Interactive Virtual Event With Technion Alumni
Featuring Technion Alumnus, Assaf Zinger ’12, Ph.D. ’18
“From a young age, I knew I am going to be a scientist, and it’s a decision I have never regretted,” said Dr. Assaf Zinger. Today, he is a rising star in biomedical engineering and nanotherapeutics.
Conducting his postdoctoral research at the Houston Methodist Research Institute in Texas, Dr. Zinger is developing personalized biomimetic (inspired by nature) nanotechnologies for drug delivery and regenerative medicine. Specifically, he is working to treat heart disease and a rare postnatal disorder known as Rett syndrome. He is also trying to find a cure for the deadly brain cancer, glioblastoma.
Join us for an interactive virtual event exclusively for the Dallas and Houston ATS community. Hear Dr. Zinger discuss how to harness the body’s healing capabilities to their fullest potential for targeting inflammation, delivering therapeutic drugs, and tissue engineering. He will also provide insights into developing a coronavirus vaccine, a process that is similar to work he is doing enclosing genetic materials into nanoparticles.
Space is limited. Please RSVP early.
ABOUT THE SPEAKER
Assaf Zinger received his degrees at the Technion: his bachelor’s degree in 2012, and his doctorate in 2018 from the Faculty of Chemical Engineering with Associate Professor Avi Schroeder. One of their many outstanding achievements involved combining enzymes with nanoscale drug delivery systems to allow for non-invasive procedures that would have otherwise required surgery. Dr. Zinger is the grandson of a Holocaust survivor and by the age of 29 had already served the Israel Defense Forces during three conflicts.